UK utility weights for the EORTC QLU-C10D

被引:46
作者
Norman, Richard [1 ]
Mercieca-Bebber, Rebecca [2 ,3 ]
Rowen, Donna [4 ]
Brazier, John E. [4 ]
Cella, David [5 ]
Pickard, A. Simon [6 ]
Street, Deborah J. [7 ]
Viney, Rosalie [8 ]
Revicki, Dennis [2 ]
King, Madeleine T. [2 ]
机构
[1] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia
[2] Univ Sydney, Fac Sci, Sch Psychol, Sydney, NSW, Australia
[3] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[4] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[6] Univ Illinois, Coll Pharm, Dept Pharm Syst Outcomes & Policy, Chicago, IL USA
[7] Univ Technol Sydney, Cl1ERE, Sydney, NSW, Australia
[8] Patient Ctr Res, Bethesda, MD USA
基金
英国医学研究理事会;
关键词
cancer; discrete choice experiment; health state valuation; utility; DISCRETE-CHOICE EXPERIMENT; PREFERENCE-BASED MEASURE; HEALTH STATES; INSTRUMENT; VALUATION; QLQ-C30; IMPACT; VALUES; QALYS;
D O I
10.1002/hec.3950
中图分类号
F [经济];
学科分类号
02 ;
摘要
The EORTC QLU-C10D is a new multi-attribute utility instrument derived from the widely used cancer-specific quality of life questionnaire, EORTC QLQ-C30. It contains 10 dimensions (physical functioning, role functioning, social functioning, emotional functioning, pain, fatigue, sleep, appetite, nausea, bowel problems), each with four levels. The aim of this study was to provide U.K. general population utility weights for the QLU-C10D. A U.K. online panel was quota-sampled to align the sample to the general population proportions of sex and age (>= 18 years). The online valuation survey included a discrete choice experiment (DCE). Each participant was asked to complete 16 choice-pairs, each comprising two QLU-C10D health states plus duration. DCE data were analysed using conditional logistic regression to generate utility weights. Data from 2,187 respondents who completed at least one choice set were included in the DCE analysis. The final U.K. QLU-C10D utility weights comprised decrements for each level of each health dimension. For nine of the 10 dimensions (all except appetite), the expected monotonic pattern was observed across levels: Utility decreased as severity increased. For the final model, consistent monotonicity was achieved by merging inconsistent adjacent levels for appetite. The largest utility decrements were associated with physical functioning and pain. The worst possible health state (the worst level of each dimension) is -0.083, which is considered slightly worse than being dead. The U.K.-specific utility weights will enable cost-utility analysis (CUA) for the economic evaluation of new oncology therapies and technologies in the United Kingdom, where CUA is commonly used to inform resource allocation.
引用
收藏
页码:1385 / 1401
页数:17
相关论文
共 50 条
  • [41] Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study
    Kawata, Ariane K.
    Lenderking, William R.
    Eseyin, Olabimpe R.
    Kerstein, David
    Huang, Joice
    Huang, Hui
    Zhang, Pingkuan
    Lin, Huamao M.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (09) : 924 - 935
  • [42] Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
    Kim, Seon Ha
    Jo, Min-Woo
    Kim, Hwa-Jung
    Ahn, Jin-Hee
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2012, 10
  • [43] Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
    Doble, Brett
    Lorgelly, Paula
    QUALITY OF LIFE RESEARCH, 2016, 25 (04) : 891 - 911
  • [44] Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients
    Kim, Eun-ju
    Ko, Su-Kyoung
    Kang, Hye-Young
    QUALITY OF LIFE RESEARCH, 2012, 21 (07) : 1193 - 1203
  • [45] Indirect and Direct Mapping of the Cancer-Specific EORTC QLQ-C30 onto EQ-5D-5L Utility Scores
    Meunier, Aurelie
    Soare, Alexandra
    Chevrou-Severac, Helene
    Myren, Karl-Johan
    Murata, Tatsunori
    Longworth, Louise
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2022, 20 (01) : 119 - 131
  • [46] Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30
    Krabbe, PFM
    Peerenboom, L
    Langenhoff, BS
    Ruers, TJM
    QUALITY OF LIFE RESEARCH, 2004, 13 (07) : 1247 - 1253
  • [47] Mapping the EORTC-QLQ-C30 to the EQ-5D-3L: An Assessment of Existing and Newly Developed Algorithms
    Woodcock, Fionn
    Doble, Brett
    MEDICAL DECISION MAKING, 2018, 38 (08) : 954 - 967
  • [48] Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30
    Paul F.M. Krabbe
    Lonneke Peerenboom
    Barbara S. Langenhoff
    Theo J.M. Ruers
    Quality of Life Research, 2004, 13 : 1247 - 1253
  • [49] Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma
    Arnold, David T.
    Rowen, Donna
    Versteegh, Matthijs M.
    Morley, Anna
    Hooper, Clare E.
    Maskell, Nicholas A.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2015, 13
  • [50] Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer
    Yasuhiro Hagiwara
    Takeru Shiroiwa
    Naruto Taira
    Takuya Kawahara
    Keiko Konomura
    Shinichi Noto
    Takashi Fukuda
    Kojiro Shimozuma
    Health and Quality of Life Outcomes, 18